Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates
Many clients have, and it changed their lives
otherwise, samples must be stored at 20C (for up to 1 month) or 80C (for up to 2 months) to avoid loss of bioactivity and contamination
2020 Sep;105:106895
Antioxidant vitamin supplementation prevents oxidative stress but does not enhance performance in young football athletes
TRZ attenuates obesity-induced AD Obesity and related cardio-metabolic disorders are associated with the development of AD (Flores-Cordero et al